| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/22/2001 | CN1308946A Chinese patent medicine for treating coronary heart disease and hypertension |
| 08/22/2001 | CN1308943A Chinese patent medicine for treating gastritis |
| 08/22/2001 | CN1308942A Tea for beautifying face and lossing weight |
| 08/22/2001 | CN1308940A Application and preparing process of nm-class biological medical stone powder |
| 08/22/2001 | CN1308933A Skin-care ecological nutritive cream of forest frog's oviduct fat and its preparing process |
| 08/22/2001 | CN1308894A Process for preparing iron-containing soy |
| 08/22/2001 | CN1069836C Medicine for treating infantile malnutrition and its preparing process |
| 08/22/2001 | CN1069833C Hand liniment |
| 08/22/2001 | CN1069832C Medicinal composition for treating bronchial asthma and its preparing process |
| 08/22/2001 | CN1069831C Patch for treating spur |
| 08/22/2001 | CN1069830C Exterior use medical ointment for treating foot disorder and its preparing process |
| 08/22/2001 | CN1069821C Iodine-enriched spirulina powder and its use |
| 08/21/2001 | US6277979 KIAA0551 polynucleotides and polypeptides use |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277836 Methods and compositions for treating inflammatory bowel disease |
| 08/21/2001 | US6277820 Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells |
| 08/21/2001 | US6277635 Use of interleukin-10 to produce a population of suppressor cells |
| 08/21/2001 | US6277621 Artificial chromosome constructs containing foreign nucleic acid sequences |
| 08/21/2001 | US6277594 Neurogenesis inducing gene |
| 08/21/2001 | US6277583 Affinity labeling libraries and applications thereof |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277557 Infusible grade short-term cell storage medium |
| 08/21/2001 | US6277556 Controlling donor blood characteristics |
| 08/21/2001 | US6277372 Porcine ventral mesencephalic cells obtained from an embryonic pig of between ages 24 and 30 of gestation from embryonic connective tissue; |
| 08/21/2001 | US6277370 Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections and related method |
| 08/21/2001 | US6277369 The selected cells can thereafter be used as vehicles for transferring genes encoding a therapeutic protein to a mammal, including humans. |
| 08/21/2001 | US6277337 Microorganisms in fluids or on surfaces. preferably the fluids contain blood or blood products and comprise biologically active proteins. |
| 08/21/2001 | CA2288407C Parathyroid hypertensive factor |
| 08/21/2001 | CA2176474C Viracidal, bactericidal and spermicidal vaginal suppository |
| 08/16/2001 | WO2001059104A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | WO2001059102A2 Nucleozymes with endonuclease activity |
| 08/16/2001 | WO2001059088A2 Vector |
| 08/16/2001 | WO2001059076A2 Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses |
| 08/16/2001 | WO2001059073A2 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 08/16/2001 | WO2001059072A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001059068A2 Artificial bone chips, methods for the production thereof and their use |
| 08/16/2001 | WO2001058936A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/16/2001 | WO2001058922A2 Method and compositions for treating hepatocellular cancer |
| 08/16/2001 | WO2001058526A2 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 08/16/2001 | WO2001058494A2 Gene therapy for treating ocular-related disorders |
| 08/16/2001 | WO2001058483A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 08/16/2001 | WO2001058482A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 08/16/2001 | WO2001058479A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | WO2001058472A2 Botulinum toxin pharmaceutical compositions |
| 08/16/2001 | WO2001058466A1 Biodegradable and biocompatible polymeric microspheres encapsulating salmonella enteritidisbacteria |
| 08/16/2001 | WO2001058465A2 Probiotic therapy for newborns |
| 08/16/2001 | WO2001058463A1 Neuronal cell division |
| 08/16/2001 | WO2001058462A2 Models, methods and materials relating to clinical conditions associated with reactive oxygen species |
| 08/16/2001 | WO2001058461A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 08/16/2001 | WO2001058460A1 Isolation and transplantation of retinal stem cells |
| 08/16/2001 | WO2001058432A1 Apparatus for providing a red blood cell carrier |
| 08/16/2001 | WO2001058431A1 Method for loading a red blood cell with an agent |
| 08/16/2001 | WO2001058413A1 Method for stimulating hair growth and kit for carrying out said method |
| 08/16/2001 | WO2001058284A1 Pharmaceutical composition for muscular anabolism |
| 08/16/2001 | WO2001058283A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | WO2001058266A1 Therapeutic platelets and methods |
| 08/16/2001 | WO2001022978A3 Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
| 08/16/2001 | WO2001012201A8 Blood plasma replacement solution |
| 08/16/2001 | WO2001009115A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007080A3 Method for enhancing production performance in an animal |
| 08/16/2001 | WO2000056356B1 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) |
| 08/16/2001 | US20010014734 Controllers |
| 08/16/2001 | US20010014674 Wound healing agent |
| 08/16/2001 | US20010014475 Aggregate suitable for implantation comprising an aggregate of cells and biodegradable microcarrier particles; cell microcarrier aggregates are grown in mold shaped to conform to the geometry of the desired body part |
| 08/16/2001 | US20010014473 Cells having ability to form extracellular cartilage matrix are brought into a cell space where they settle on a plate in a culture medium for producing extracellular cartilage matrix |
| 08/16/2001 | US20010014471 Antitumor agents |
| 08/16/2001 | US20010014320 Administering to recipient, prior to administration of the hematopoietic system reconstituting cells, an amount of mononuclear cells treated so as to render them incapable of proliferating and causing lethal graft versus host disease |
| 08/16/2001 | US20010014319 Defective recombinant virus containing at least one inserted gene encoding all or part of lecithin-cholesterol acyltransferase (LCAT) or a variant thereof; treating or preventing dyslipoproteinaemia-related diseases |
| 08/16/2001 | US20010014311 External preparation for skin |
| 08/16/2001 | EP1123707A2 Use of a liver extract and liver extract thereof |
| 08/16/2001 | EP1123706A1 Neuronal cell division |
| 08/16/2001 | EP1123396A2 Minimal promoters and uses thereof |
| 08/16/2001 | EP1123384A2 Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 08/16/2001 | EP1123383A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/16/2001 | EP1123368A1 Method of extracting lipids from marine and aquatic animal tissues |
| 08/16/2001 | EP1123314A2 USE OF A CYTOKINE-PRODUCING $i(LACTOCOCCUS) STRAIN TO TREAT COLITIS |
| 08/16/2001 | EP1123123A1 Biological fluid filter and system |
| 08/16/2001 | EP1123105A1 Solid phase quenching systems |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | EP1123067A2 Cardiovascular components for transplantation and methods of making thereof |
| 08/16/2001 | EP1007630A4 Natural killer cell lines and methods of use |
| 08/16/2001 | DE19960504A1 Regenerationsmittel Regenerant |
| 08/16/2001 | DE19955274A1 Verfahren gegen Multiresistenzen und starke Resistenzen Proceedings against multi-drug resistance and strong resistance |
| 08/16/2001 | DE10004857A1 MLP-Gen, Nukleinsäuren, Polypeptide und deren Verwendung MLP-gene nucleic acids, polypeptides and their use |
| 08/16/2001 | CA2400488A1 Methods for the prevention and treatment of infections using anti-c3b(i) antibodies |
| 08/16/2001 | CA2399969A1 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 08/16/2001 | CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | CA2399623A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | CA2398990A1 Pharmaceutical composition for muscular anabolism |
| 08/16/2001 | CA2398984A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398750A1 Nucleozymes with endonuclease activity |
| 08/16/2001 | CA2398571A1 Materials and methods for treating ocular-related disorders |
| 08/16/2001 | CA2398136A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | CA2397362A1 Therapeutic platelets and methods |
| 08/15/2001 | CN1308540A Anti-diarrheal and method for using the same |
| 08/15/2001 | CN1307896A Preparation of pile-eliminating turtle shell capsule |
| 08/15/2001 | CN1307894A Plaster for treating hyperosteogeny and arthrosis |